Annual Meeting
-
Mark your calendars for CHEST 2025 in Chicago
Celebrate a rich history of clinical and educational excellence and focus on the innovative future of chest medicine, October 19 to 22, 2025.
-
HCA Florida Aventura Hospital wins CHEST Challenge in Boston
Fellows from HCA Florida Aventura Hospital, NewYork-Presbyterian Brooklyn Methodist Hospital, and Allegheny Health Network competed in creative clinical trivia and live challenges during CHEST 2024.
-
Panelists share advice for navigating CHEST guideline development process
Israa Soghier, MD, MS, detailed how to pick a diverse team of experts and avoid potential conflicts of interest when developing guidelines for publication through CHEST.
-
Discussion highlights latest approaches, trends in nicotine dependence treatment
Andrew Salomon, MD, addressed cultural and racial inequities in statistics for tobacco use and cessation and nicotine dependence therapy.
-
Session addresses complexity of evaluating and managing worsening patients with PH-ILD
Tejaswini Kulkarni, MD, MPH, discussed best care practices for clinical worsening patients with PH associated with ILD.
-
Panel discussion reviews benefits, risks of surgery for PE
Timothy M. Fernandes, MD, MPH, FCCP, and fellow panelists explored complications of PE and related conditions that may lead physicians to consider surgical procedures.
-
Clinicians outline transition from recalled home ventilators to new modes, devices
Jorge I. Mora, MD, FCCP, and other experts walked attendees through the current home mechanical ventilation market, including differences and similarities.
-
Close out CHEST 2024 with can’t-miss Wednesday sessions
Listen to today’s podcast for a preview of Wednesday’s schedule from Chair of the Scientific Program Committee, Gabriel Bosslet, MD, FCCP, and his guest, CHEST 2025 Chair, Sandhya Khurana, MD, FCCP.
-
Panelists review overlap, differences in EPR-4, GINA guidelines for asthma treatment
Jerry A. Krishnan, MD, PhD, FCCP, presented an overview of EPR-4 and GINA guidelines for Steps 3 through 5 in moderate to severe asthma during a Tuesday morning session.
-
Experts outline new, under-recognized factors driving occupational lung disease
Susan Armstrong, MD, PhD, walked attendees through key features of occupational lung disease from a pathologist’s perspective during a Tuesday morning session.